Welcome to MedTech Trailblazers where Andrew Cleeland, CEO of Fogarty Innovation, hosts in-depth conversations with the disruptors and innovators in the field of medical technology. Join him as he shares their insightful stories, effective leadership styles and what they're doing to transform patient outcomes and shape the future of human health.
…
continue reading
1
Leading With His Heart - A Conversation with Allan Will (Part 2)
24:14
24:14
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
24:14
Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one …
…
continue reading
1
Leading With His Heart - A Conversation with Allan Will (Part 1)
29:29
29:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:29
Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one …
…
continue reading
1
Sam Conaway: Turning Obstacles into Opportunities - Part 2
32:09
32:09
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
32:09
Sam Conaway is the president of U.S. Cardiology Sales for Boston Scientific and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org)…
…
continue reading
1
Sam Conaway: Turning Obstacles into Opportunities - Part 1
36:35
36:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
36:35
Sam Conaway is the president of U.S. Cardiology Sales for Boston Scientific and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org)…
…
continue reading
1
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials - Part 2
31:50
31:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
31:50
Kendal Whitlock is a problem solver. In her current position as the Head of Digital Optimization, RWE Clinical Trials for Walgreens Boots Alliance, she is working to make it possible for all patients to participate in medical research, regardless of where they live, through decentralized clinical trials and enabling digital technologies. In this se…
…
continue reading
1
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials
26:16
26:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
26:16
…
continue reading
1
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 2)
34:23
34:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
34:23
In this second of two parts, serial innovator and entrepreneur Mir Imran rejoins Andrew Cleeland, CEO of Fogarty Innovation, to discuss his reluctant path through medical school, the inspiration that led him to develop the first automatic implantable cardiac defibrillator, how he views innovation and chooses problems to solve, and the stories behin…
…
continue reading
1
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 1)
27:04
27:04
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
27:04
Mir Imran has an insatiable interest in unsolved clinical problems and a relentless entrepreneurial drive. The result has been a 40-year career developing and commercializing breakthrough medical technologies that have saved millions of lives. Mir has helped shape the medical device industry, founding more than 20 life science companies including V…
…
continue reading
1
John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 2)
23:20
23:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
23:20
World-renowned physician, venture capitalist and prolific entrepreneur, John Simpson, MD, rejoins Andrew Cleeland to discuss the impact he's had on the future generation of medtech innovators. Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helpi…
…
continue reading
1
John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 1)
28:27
28:27
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
28:27
A husband, father, world-renowned physician, venture capitalist and prolific entrepreneur, John Simpson, MD, has helped revolutionize the field of cardiology via his innovations. Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helping to create t…
…
continue reading
1
Cardiologist Marty Leon Transforms Personal Adversity to Create Pioneering Career (Part 2)
25:20
25:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
25:20
Andrew Cleeland, CEO of Fogarty Innovation, welcomes back world-renowned cardiologist Dr. Marty Leon, a visionary leader who has shaped the worldwide practice of interventional medicine. Dr. Leon is professor of medicine at Columbia University Irving Medical Center (CUIMC), Director of Columbia Interventional Cardiovascular Care and of the Cardiac …
…
continue reading
1
Cardiologist Marty Leon Transforms Personal Adversity to Create Pioneering Career (Episode 1)
36:19
36:19
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
36:19
There is virtually no aspect of the cardiovascular health ecosystem that hasn’t been impacted by the work of Dr. Marty Leon, professor of medicine at Columbia University Irving Medical Center (CUIMC) and a legendary interventional cardiologist whose many roles and accomplishments have had an indelible effect on the practice of cardiology and the me…
…
continue reading
While he needs no introduction, it’s always an honor to list Dr. Tom Fogarty’s many accomplishments over his nearly eight-decade career as one of the medical device industry’s most prolific inventors. Dr. Fogarty has had a profound and lasting impact on patients, on healthcare, on innovation on our industry and many of its leaders. As an internatio…
…
continue reading
1
Hanson Gifford Shares Tales of An Illustrious Career -- Episode 2
28:56
28:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
28:56
Dubbed as a “walking encyclopedia of medtech experiences, innovations and impact,” Hanson Gifford, CEO and managing director of The Foundry, has been directly involved with or founded over 30 companies in the past 40 years. In this episode, he rejoins Andrew Cleeland, CEO of Fogarty Innovation, as he shares his views on teamwork, investing, digital…
…
continue reading
1
Hanson Gifford Shares Tales of An Illustrious Career -- Episode 1
30:11
30:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:11
Hanson Gifford, CEO and managing partner of The Foundry, is perhaps best known as a co-founder of this iconic Silicon Valley-based incubator that has blazed the path for numerous successful medtech companies, developing cutting-edge treatments that address a broad range of large, unmet clinical needs. In this episode, he joins Andrew Cleeland as he…
…
continue reading
1
The Essential Role Jan Garfinkle has Played in the Medtech Ecosystem — Part 2
36:00
36:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
36:00
Jan Garfinkle, founder and managing partner of Arboretum Ventures, rejoins Andrew Cleeland as she shares the reasons behind launching the firm and the grit it took to get the company started. Jan also discusses the pivotal role she played at the National Venture Capital Association (NVCA) to help ensure venture-backed startups could apply for PPP l…
…
continue reading
1
The Essential Role Jan Garfinkle has Played in the Medtech Ecosystem —Part 1
33:02
33:02
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
33:02
Jan Garfinkle, founder and managing partner of Arboretum Ventures, has played a key role in multiple foundational companies in the medtech industry. Today, she supports the early-medtech ecosystem at the firm with a mission that is similar to Fogarty Innovation's: driving down the costs of healthcare through innovation. Arboretum has invested in 60…
…
continue reading
1
A Salute to Paul Yock, MD, and His Legacy, Part 2
22:05
22:05
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
22:05
Paul Yock, MD, has had an unparalleled career as an accomplished physician, innovator and educator. In retrospect, Paul is proudest of the Stanford Biodesign program trainees, many of whom have gone on to lead health technology start-up companies, found innovation training programs, become faculty members of major universities, or return to clinica…
…
continue reading
1
A Salute to Paul Yock, MD, and His Legacy, Part 1
24:30
24:30
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
24:30
“In addition to the vast impact his inventions have had, I believe Paul’s multifaceted legacy will be kept by his influence on the innovators of today and generations well into the future." The iconic Paul Yock, MD, joins Andrew Cleeland as he provides a glimpse into his stellar career as an accomplished physician, innovator and educator. Paul is t…
…
continue reading
1
The Quintessential Entrepreneur: An Interview with Josh Makower, Part 2
35:12
35:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
35:12
Josh Makower, MD, rejoins Andrew Cleeland as he shares his experience working at Pfizer, breaking new ground by launching ExploraMed, and coming full circle as co-founder and now director of Stanford Biodesign.
…
continue reading
1
The Quintessential Entrepreneur: An interview with Josh Makower, Part 1
21:29
21:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:29
Anyone who’s spent time in the medtech field knows that the name Josh Makower is synonymous with innovation, as he has blazed numerous trails for new technologies and therapies alike. Josh cut his teeth at Pfizer, then went on to become the quintessential entrepreneur, founding eight medtech companies in a variety of clinical specialties including …
…
continue reading
1
A Rocket to the Moon Part 2: A Conversation with Casey McGlynn
21:33
21:33
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:33
Casey McGlynn, a founding architect of the MedTech industry, has been guiding and connecting innovators and operators for more than 3 decades. He is a partner at Wilson Sonsini Goodrich & Rosati and has played such a pivotal role in MedTech that the industry would look very different if not for his contributions. He rejoins Andrew Cleeland to share…
…
continue reading
1
A Rocket to the Moon: A Conversation with Casey McGlynn
22:23
22:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
22:23
Casey McGlynn is a partner at Wilson Sonsini Goodrich & Rosati. He is a founding architect of the medtech industry and has been guiding and connecting innovators for more than three decades. Casey has played a pivotal role in the medtech industry: his legacy is so vast that the industry would not be what it is today without his contributions. He jo…
…
continue reading
1
A Born Leader Part 2: A Conversation with Ginger Graham
35:50
35:50
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
35:50
Fogarty Innovation による
…
continue reading
1
A Born Leader: A conversation with Ginger Graham, Part 1
30:02
30:02
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:02
The field of MedTech uses the latest technology to address medical challenges and find new ways to transform patient care. The industry is filled with groundbreaking experts paving the way to a better and healthier future— transforming patient care and saving countless lives. In this exciting new podcast, Andrew Cleeland invites listeners to tune i…
…
continue reading
Welcome to MedTech Trailblazers where Fogarty Innovation's CEO Andrew Cleeland is talking to the experts and innovators changing the future of healthcare. Find out what this podcast is going to cover, and how it came to be.Fogarty Innovation による
…
continue reading